» Articles » PMID: 33709323

Implementing Implementation Research: Teaching Implementation Research to HIV Researchers

Overview
Publisher Current Science
Date 2021 Mar 12
PMID 33709323
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Given the growth in HIV-related implementation research, there is a need to expand the workforce and rigor through implementation science (IS) training and mentorship. Our objective is to review IS training opportunities for HIV-focused researchers and describe the approach and lessons learned from a recent HIV-related implementation research training initiative.

Recent Findings: IS training opportunities range from degree programs to short- and longer-term professional development institutes and community-focused institutional trainings. Until recently, there have not been extensive dedicated opportunities for implementation research training for HIV-focused investigators. To meet this gap, an inter-Center for AIDS Research IS Fellowship for early-stage investigators was launched in 2019, building on lessons learned from dissemination and implementation training programs. Key components of the HIV-focused IS fellowship include didactic training, mentorship, grant-writing, and development of HIV-IS collaborative networks. Fellows to-date were two-thirds junior faculty and one-third post-doctoral fellows, the majority (69%) with prior public health training. Perceived value of the program was high, with a median rating of 9 [IQR 8-9] on a 10-point scale. Overall, 22/27 (81%) Fellows from the first cohort submitted IS-related grants within 12 months of Fellowship completion, and by 1 year 13 grants had been funded among 10 investigators, 37% overall among Fellows. Mentors identified framing of IS questions as the top-ranked training priority for HIV-investigators. Increasing knowledge of the utility of IS may support more grants focused on optimal implementation of HIV treatment and prevention strategies. Experiences from mentors and trainees engaged in an IS-focused fellowship for HIV investigators demonstrate the demand and value of a dedicated training program and reinforce the importance of mentorship.

Citing Articles

Innovations for building implementation science capacity among researchers and policymakers: The Depth and Diffusion Model.

Bartels S, Hoang V, Giang L, Thu T, Dyk Q, Sripaipan T Glob Implement Res Appl. 2025; 4(3):272-285.

PMID: 40052002 PMC: 11884728. DOI: 10.1007/s43477-024-00121-x.


Barriers and Facilitators of Research Finding Utilization in Healthcare: A Scoping Review.

Zareivenovel M, Nemati-Anaraki L, Asadzandi S Iran J Public Health. 2025; 53(12):2646-2658.

PMID: 39759203 PMC: 11693791.


Navigating grey areas in HIV and mental health implementation science.

Harkness A, Giusto A, Hamilton A, Hernandez-Ramirez R, Spiegelman D, Weiner B J Int AIDS Soc. 2024; 27(6):e26271.

PMID: 38923301 PMC: 11197965. DOI: 10.1002/jia2.26271.


Reflections on 10 years of effectiveness-implementation hybrid studies.

Curran G, Landes S, McBain S, Pyne J, Smith J, Fernandez M Front Health Serv. 2023; 2:1053496.

PMID: 36925811 PMC: 10012680. DOI: 10.3389/frhs.2022.1053496.


Supporting the Growth of Domestic HIV Implementation Research in the United States Through Coordination, Consultation, and Collaboration: How We Got Here and Where We Are Headed.

Mustanski B, Smith J, Keiser B, Li D, Benbow N J Acquir Immune Defic Syndr. 2022; 90(S1):S1-S8.

PMID: 35703749 PMC: 9643076. DOI: 10.1097/QAI.0000000000002959.

References
1.
Rodger A, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O . Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet. 2019; 393(10189):2428-2438. PMC: 6584382. DOI: 10.1016/S0140-6736(19)30418-0. View

2.
Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505. PMC: 3200068. DOI: 10.1056/NEJMoa1105243. View

3.
Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

4.
McCormack S, Dunn D, Desai M, Dolling D, Gafos M, Gilson R . Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2015; 387(10013):53-60. PMC: 4700047. DOI: 10.1016/S0140-6736(15)00056-2. View

5.
Baeten J, Donnell D, Ndase P, Mugo N, Campbell J, Wangisi J . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. PMC: 3770474. DOI: 10.1056/NEJMoa1108524. View